Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Impact of Baseline GLP-1 Receptor Agonist Use on Albuminuria Reduction and Safety With Simultaneous Initiation of Finerenone and Empagliflozin in Type 2 Diabetes and Chronic Kidney Disease (CONFIDENCE Trial)
PaperCitations, authors & open-access status
Impact of Baseline GLP-1 Receptor Agonist Use on Albuminuria Reduction and Safety With Simultaneous Initiation of Finerenone and Empagliflozin in Type 2 Diabetes and Chronic Kidney Disease (CONFIDENCE Trial) is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 12 citations, 2025 year and green oa status.
12
Citations
2025
Year
green
OA Status